Amyotrophic lateral sclerosis: cell vulnerability or system vulnerability? by Talbot, K

Amyotrophic lateral sclerosis: Cell vulnerability or system vulnerability? by Talbot, K

Do twin studies still have anything to teach us about the genetics of amyotrophic lateral sclerosis? by Talbot, K

Familial versus sporadic amyotrophic lateral sclerosis -A false dichotomy? by Talbot, K

Neuromuscular disorders: therapeutic advances. by Talbot, K

Editorial: Another gene for ALS: Mutations in sporadic cases and the rare variant hypothesis by Talbot, K

Motor neurone disease. by Talbot, K

Motor neuron disease: the bare essentials. by Talbot, K

The study of rare diseases: butterfly collecting or an entree to understanding common conditions? by Talbot, K

Motor neuron disease by Talbot, K

Should all patients with ALS have genetic testing? by Talbot, K

Another gene for ALS: mutations in sporadic cases and the rare variant hypothesis. by Talbot, K

Monomelic amyotrophy or Hirayama's disease by Talbot, K

Should all patients with ALS have genetic testing? by Talbot, K

Clinical tool for predicting survival in ALS: do we need one? by Talbot, K

Familial versus sporadic amyotrophic lateral sclerosis--a false dichotomy? by Talbot, K

Spinal muscular atrophy at the crossroads of basic science and therapy by Sleigh, J, Grice, S, Davies, K, Talbot, K, Talbot, K

Spinal muscular atrophy. by Talbot, K, Davies, K

A calm before the exome storm: coming together of dSMA and CMT2. by Hoffman, E, Talbot, K

The molecular genetics of non-ALS motor neuron diseases. by James, P, Talbot, K